Aprea Therapeutics, Inc.
APRENASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $33.03M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.55$1.69
- Volume (live)
- -
- Avg. volume (3M)
- 216.78K
Aprea Therapeutics (APRE) Stock Price & Financial Analysis
Aprea Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.57 - $0.66 |
|---|---|
| 52-Week High | $1.69 |
| 52-Week Low | $0.55 |
| Open | $0.66 |
| Volume (last close) | 159.85K |
| Average Volume (3M) | 216.78K |
| Revenue (TTM) | 3.34K |
|---|---|
| Net Income (TTM) | -12.31M |
| Free Cash Flow (TTM) | -12.18M |
| EPS (TTM) | −$0.60 |
| Profit Margin | -368812.14% |
| Operating Margin | -396256.31% |
| Return on Equity (ROE) | -31.99% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 33.03M |
|---|---|
| Shares Outstanding | 53.48M |
| Price to Sales (P/S) | 9898.54 |
| Price to Book (P/B) | 0.86 |
| EV/EBITDA | 0.63 |
| 50-Day MA | $0.73 |
|---|---|
| 200-Day MA | $0.78 |
| 1-Year Change | −60.66% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Aprea Therapeutics at a Glance
As of the Oct 16, 2026 close, Aprea Therapeutics (APRE) has a market capitalization of $33.03M. The stock trades at 9898.5× sales. Over the trailing twelve months it lost $12.31M on revenue of $3.34K and burned $12.18M of free cash flow. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $41.23M in cash and securities against $0.00 of debt, a net cash position of $41.23M.
Aprea Therapeutics does not currently pay a dividend.
The share price is down 60.7% over the past year. At $0.58 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.55 to $1.69, below its 200-day moving average of $0.78.
Frequently Asked Questions About Aprea Therapeutics
What is the current stock price for APRE?
As of the Oct 16, 2026 close, APRE stock trades at $0.58. The 52-week range is $0.55–$1.69, with a day range of $0.57–$0.66.
What is the P/E ratio for APRE?
The P/E ratio (Price-to-Earnings) for APRE is shown in the Key Statistics section. This valuation metric helps compare Aprea Therapeutics, Inc. to industry peers.
Does APRE pay dividends?
Aprea Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for APRE?
Analyst ratings and recommendations for APRE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of APRE?
As of the Oct 16, 2026 close, Aprea Therapeutics's market capitalization is $31.2M, classifying it as a micro-cap company. Aprea Therapeutics operates in the Healthcare sector within the Biotechnology industry.